百龙创园涨3.74%，成交额9154.56万元，近3日主力净流入-1093.77万

Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., has shown significant growth in revenue and profit, benefiting from its unique product offerings and market positioning in the health sweetener sector. Group 1: Company Overview - The company specializes in the research, production, and sales of prebiotic products, dietary fiber products, starch sugar (alcohol) products, and health sweeteners, with a revenue composition of 54.15% from dietary fiber, 28.00% from prebiotics, 13.57% from health sweeteners, and 3.91% from other products [8] - As of October 31, the number of shareholders increased by 3.75% to 13,400, while the average circulating shares per person decreased by 3.62% to 31,274 shares [8] Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 969 million yuan, representing a year-on-year growth of 18.10%, and a net profit attributable to the parent company of 265 million yuan, with a year-on-year increase of 44.93% [8] - The company has distributed a total of 183 million yuan in dividends since its A-share listing, with 172 million yuan distributed in the last three years [9] Group 3: Market Position and Benefits - The company produces allulose, a rare monosaccharide that serves as a low-calorie alternative to sucrose, making it ideal for individuals with obesity and diabetes [2] - The company holds a 5.14% stake in Shandong Yucheng Rural Commercial Bank, which may provide additional financial benefits [3] - The company has a significant overseas revenue share of 60.62%, benefiting from the depreciation of the RMB [4] - The company has been recognized as a "specialized, refined, characteristic, and innovative" small giant enterprise, which enhances its competitiveness and stability within the industry [4] Group 4: Stock Performance and Trading Activity - On November 24, the company's stock rose by 3.74%, with a trading volume of 91.55 million yuan and a turnover rate of 1.09%, bringing the total market capitalization to 8.497 billion yuan [1] - The average trading cost of the stock is 20.57 yuan, with recent selling pressure observed, indicating a need for potential portfolio adjustments [7]